Nanotechnology News

RSS

Strain-Tuning Causes Nanodefects to Self-Assemble within Superconducting Film

Researchers at the Department of Energy's Oak Ridge National Laboratory have reported progress in fabricating advanced materials at the nanoscale. The spontaneous self-assembly of nanostructures composed of multiple elements paves the way toward materials that could improve a range of energy efficient technologies and data storage devices.

From Oak Ridge National Laboratory 14 Nov 2012

BDA AFS AMS Delivers Fast Mixed-Signal Verification with Nanometer SPICE Accuracy

Berkeley Design Automation, Inc., provider of the world’s fastest nanometer circuit verification, today announced the availability of Analog FastSPICE™ AMS (AFS AMS) which delivers the industry’s simplest, fastest, most-accurate verification of today’s complex nanometer-scale mixed-signal circuits. AFS AMS combines the award winning, foundry certified Analog FastSPICE circuit simulator with any leading Verilog® hardware description language (HDL) simulator to provide full Verilog-AMS language support.

14 Nov 2012

Laser Fluorescence Spectroscopy Determines Absolute Density of Radicals in Plasma

An international team of scientists working at the Plasma Technology research unit at Ghent University, Belgium, has determined for the first time the absolute density of active substances called radicals found in a state of matter known as plasma, in a study about to be published in EPJ D. These findings could have important implications for medicine—for example, for stimulating tissue regeneration, or to induce a targeted antiseptic effect in vivo without affecting neighbouring tissues.

From Springer - Science and Technology Publishers 14 Nov 2012

Jellyfish-Inspired Microfluidic Device Isolates Circulating Tumor Cells

Tumor cells circulating in a patient’s bloodstream can yield a great deal of information on how a tumor is responding to treatment and what drugs might be more effective against it. But first, these rare cells have to be captured and isolated from the many other cells found in a blood sample.

14 Nov 2012

Researchers Use Atomic Force Microscopy to Study Amyloid Fibrils

Researchers at ETH Zürich, EPF Lausanne and at the University of Fribourg have evidenced a basic general mechanism describing how filamentous proteins assemble into ribbon like structures, the so-called Amyloid fibrils. Combining experiments and theory, they could explain how denatured milk proteins assemble into ribbon like structures composed of up to five filaments. These findings are shining a surprisingly new light on the assembly of these proteins.

14 Nov 2012

Viruses Use One-Nanometer Needle-Like Tip to Attack Bacteria

It could be the tiniest armor-piercing weapon in the biological universe: EPFL scientists have measured a one-nanometer needle-like tip that viruses use to attack bacteria.

14 Nov 2012

Speaker Line-Up Announced for Graphene International Conference in April 2013

The 3rd edition of Graphene international conference will be held next spring under the umbrella of ImagineNano event in Spain between the 23rd and 26th of April 2013. Renowned speakers on the field already confirmed ...

14 Nov 2012

NanoSight's NTA Enables Breakthrough Cancer Metastasis Research

NanoSight, leading manufacturers of unique nanoparticle characterization technology, reports on the breakthrough cancer metastasis research of Dr. Hector Peinado Selgas and Dr. David Lyden's research team from Weill Cornell Medical College.

13 Nov 2012

Oxford Instruments Enters Distribution Agreement for Dune Sciences FIB Sample Preparation Equipment

Oxford Instruments and Dune Sciences, Inc. have entered into an exclusive worldwide distribution agreement to sell Silicon Half Grids for in situ lift-out. The Dune Sciences' Silicon Half Grids will be offered ...

From Oxford Instruments NanoAnalysis 13 Nov 2012

STMicroelectronics and Xsens Unveil First Wearable MEMS 3D Body Motion Tracking System

Xsens, the leading innovator in 3D motion tracking technology and products, and STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications and the world's top manufacturer of Micro-Electro-Mechanical Systems (MEMS)1, are demonstrating the world's first wearable wireless 3D body motion tracking system based on consumer-grade MEMS combo sensors at Electronica 2012 in Munich, Germany.

From STMicroelectronics 9 Nov 2012

X-FAB’s First-of-its-Kind SOI Foundry Technology Offers 200V MOS Capability at 180 nm

X-FAB Silicon Foundries today announced its XT018, the world’s first trench dielectric isolated SOI foundry technology offering for 200V MOS capability at 180nm. Using the full dielectric isolation of this modular process allows blocks at different voltage levels to be integrated on a single chip instead of placed on different chips. It significantly reduces the number of required additional components on printed circuit boards, eliminates latch-up and provides built-in robustness against electromagnetic interference.

9 Nov 2012

Innovative Model Provides New Insights into Nanopore Sequencing

As nanotechnology progresses, it becomes increasingly important to know in detail the dynamics of the nanoworld (the world at the scale of a millionth of a millimeter). What happens, for example, when we try to drive a p...

9 Nov 2012

Reverse Costing Analysis Report on InvenSense MPU-9150 MEMS

Research and Markets has announced the addition of the "InvenSense MPU-9150 Motion Processing Unit Reverse Costing Analysis" report to their offering.

From Research and Markets 9 Nov 2012

New Tool to Understand Working Mechanism of Sliding Friction in Nanotribology

A study published by Andrea Vanossi, Nicola Manini and Erio Tosatti - three SISSA researchers - in PNAS (Proceedings of the National Academy of Sciences) provides a new tool to better understand how sliding friction works in nanotribology, through colloidal crystals.

9 Nov 2012

First Demonstration of Cancer Drug Delivery in Humans Using Minicells

A completely new way of delivering anti-cancer drugs to tumours, using 'minicells' derived from bacteria, has been tested for the first time in humans and found to be safe, well-tolerated and even induced stable disease in patients with advanced, incurable cancers with no treatment options remaining.

9 Nov 2012